Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-Myc pathway in cervical cancer cells

被引:6
|
作者
Wu, Yan [1 ]
Zhang, Li [1 ]
Bao, Yiming [1 ]
Wan, Biao [1 ]
Shu, Dan [1 ]
Luo, Tingting [1 ]
He, Zengli [2 ]
机构
[1] Chongqing Univ, Gynecol, Three Gorges Hosp, Chongqing, Peoples R China
[2] Chongqing Univ, Three Gorges Hosp, Obstet, 297 Jiangnan Ave, Chongqing, Peoples R China
关键词
Cervical cancer; c-Myc; glucose metabolism; PFKFB4; U0126; CARCINOMA; PROLIFERATION; EXPRESSION;
D O I
10.1080/01443615.2022.2062225
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4) was reported to be necessary for tumour growth in several cancers. However, the function of PFKFB4 in cervical cancer has not been clearly elucidated. Bioinformatics analysis was applied to detect the expression of PFKFB4 in cervical cancer and the association with survival prognosis. The effect of PFKFB4 on cervical cancer cells growth, cycle, invasion, migration and glucose metabolism was investigated by loss-of-function approaches in vitro. The association between PFKFB4 and MEK/ERK/c-Myc pathway was identified by western blot assay. We found that PFKFB4 was highly expressed in cervical cancer samples and its overexpression led to a poor prognosis of cervical cancer patients. Knock down of PFKFB4 reduced cell growth, blocked cell cycle, inhibited cell invasion and migration, and blocked glucose metabolism in cervical cancer cells. Our findings afforded a theoretical basis for further research on the treatment of cervical cancer based on the control of PFKFB4 expression. Impact Statement What is already known on this subject? PFKFB4 was overexpressed in several kinds of cancers and its requirement for tumour growth has been confirmed in cancers such as glioma and breast cancer. However, the function of PFKFB4 in cervical cancer cells has not been clearly elucidated. A bioinformatics study showed that PFKFB4 was a member of a six-gene signature associated with glycolysis to predict the prognosis of patients with cervical cancer. However, the relationship between PFKFB4 and glucose metabolism in cervical cancer has not been revealed. What do the results of this study add? Our results showed that PFKFB4 was highly expressed in cervical cancer samples and its overexpression led to a poor prognosis of cervical cancer patients. Moreover, the administration of si-PFKFB4 significantly reduced cell growth ability, blocked cell cycle, restrained the mobility and suppressed the glucose metabolism in cervical cancer cells partially by inactivating MEK/ERK/c-Myc pathway. What are the implications of these findings for clinical practice and/or further research? Our findings afforded a theoretical basis for further research on the treatment of cervical cancer based on the control of PFKFB4 expression.
引用
收藏
页码:2399 / 2405
页数:7
相关论文
共 50 条
  • [21] ORAI3 silencing alters cell proliferation and cell cycle progression via c-myc pathway in breast cancer cells
    Faouzi, Malika
    Kischel, Philippe
    Hague, Frederic
    Ahidouch, Ahmed
    Benzerdjeb, Nazim
    Sevestre, Henri
    Penner, Reinhold
    Ouadid-Ahidouch, Halima
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2013, 1833 (03): : 752 - 760
  • [22] Inhibition of sphingosine kinase 2 down-regulates ERK/c-Myc pathway and reduces cell proliferation in human epithelial ovarian cancer
    Dai, Lan
    Wang, Wenjing
    Liu, Yixuan
    Song, Keqi
    Di, Wen
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (08)
  • [23] Taiwanin E Induces Cell Cycle Arrest and Apoptosis in Arecoline/4-NQO-Induced Oral Cancer Cells Through Modulation of the ERK Signaling Pathway
    Wang, Shih-Hao
    Wu, Hsi-Chin
    Badrealam, Khan Farheen
    Kuo, Yueh-Hsiung
    Chao, Yun-Peng
    Hsu, Hsi-Hsien
    Bau, Da-Tian
    Viswanadha, Vijaya Padma
    Chen, Yi-Hui
    Lio, Pei-Jei
    Chiang, Chung-Jen
    Huang, Chih-Yang
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [24] Fucosterol exerts antiproliferative effects on human lung cancer cells by inducing apoptosis, cell cycle arrest and targeting of Raf/MEK/ERK signalling pathway
    Mao Zhangfan
    Shen Xiaoling
    Dong Ping
    Liu Gaoli
    Pan Shize
    Sun Xiangran
    Hu Haifeng
    Pan Li
    Huang Jie
    PHYTOMEDICINE, 2019, 61
  • [25] NCAPH promotes glucose metabolism reprogramming and cell stemness in ovarian cancer cells through the MEK/ERK/PD-L1 pathway
    Yingying Qi
    Aiping Wang
    Silin Chen
    Wei Chen
    Journal of Ovarian Research, 18 (1)
  • [26] Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer
    Yang, Liqun
    Lei, Qian
    Li, Lin
    Yang, Jie
    Dong, Zhen
    Cui, Hongjuan
    CLINICAL EPIGENETICS, 2019, 11 (01)
  • [27] Silencing or inhibition of H3K79 methyltransferase DOT1L induces cell cycle arrest by epigenetically modulating c-Myc expression in colorectal cancer
    Liqun Yang
    Qian Lei
    Lin Li
    Jie Yang
    Zhen Dong
    Hongjuan Cui
    Clinical Epigenetics, 2019, 11
  • [28] Trichodermin Induces G0/G1 Cell Cycle Arrest by Inhibiting c-Myc in Ovarian Cancer Cells and Tumor Xenograft-Bearing Mice
    Gao, Ying
    Miles, Sarah L.
    Dasgupta, Piyali
    Rankin, Gary O.
    Cutler, Stephen
    Chen, Yi Charlie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [29] Bisphenol A induces cell cycle arrest in primary and prostate cancer cells through EGFR/ERK/p53 signaling pathway activation
    Bilancio, Antonio
    Bontempo, Paola
    Di Donato, Marzia
    Conte, Mariarosaria
    Giovannelli, Pia
    Altucci, Lucia
    Migliaccio, Antimo
    Castoria, Gabriella
    ONCOTARGET, 2017, 8 (70) : 115620 - 115631
  • [30] COMBINATION OF BERBERINE AND MATRINE INDUCES INTRINSIC APOPTOTIC PATHWAY AND G1 CELL CYCLE ARREST IN HUMAN CERVICAL CANCER CELLS
    Zhang, Qijiayu
    Sun, Yi
    Huang, Yu-Xi
    Sun, Jing
    Zhao, Chong-Bo
    Song, Yi-Jun
    Wu, Jian-Hua
    ACTA POLONIAE PHARMACEUTICA, 2019, 76 (06): : 1089 - 1097